Related references
Note: Only part of the references are listed.STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion
Chuan-xia Zhang et al.
CELL DEATH AND DIFFERENTIATION (2019)
Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling
Viktor Fleming et al.
CANCER RESEARCH (2019)
Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
Philipp Metzger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles
Angelica Ortiz et al.
CANCER CELL (2019)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells
Wei Xiao et al.
JOURNAL OF IMMUNOLOGY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Unique pattern of neutrophil migration and function during tumor progression
Sima Patel et al.
NATURE IMMUNOLOGY (2018)
IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections
Kelly M. Shepardson et al.
FRONTIERS IN IMMUNOLOGY (2018)
Chronic Type I IFN Is Sufficient To Promote Immunosuppression through Accumulation of Myeloid-Derived Suppressor Cells
Kahina Taleb et al.
JOURNAL OF IMMUNOLOGY (2017)
Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy
Neha Kamran et al.
MOLECULAR THERAPY (2017)
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Xin Lu et al.
NATURE (2017)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Hua Liang et al.
NATURE COMMUNICATIONS (2017)
Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
Guoliang Yang et al.
ONCOTARGET (2017)
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
Yago Pico de Coana et al.
ONCOTARGET (2017)
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models
Yuichi Iida et al.
CANCER SCIENCE (2017)
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
Ruth J. Davis et al.
CANCER RESEARCH (2017)
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment
Kanstantsin V. Katlinski et al.
CANCER CELL (2017)
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Sung-Eun Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Significance of Circulating CD33+ CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
Moshe Sade-Feldman et al.
CLINICAL CANCER RESEARCH (2016)
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent
Trevor E. Angell et al.
THYROID (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V. Katlinskaya et al.
CELL REPORTS (2016)
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
Jeffrey Weber et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients
Kohei Tada et al.
CANCER IMMUNOLOGY RESEARCH (2016)
The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis
Shuo Zhang et al.
PLOS ONE (2016)
Identification of CD4+CD25+CD127- regulatory T cells and CD14+HLA-DR-/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancer
Jinhu Wang et al.
BIOMEDICAL REPORTS (2016)
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine et al.
SCIENCE IMMUNOLOGY (2016)
Innate Immune Recognition of Cancer
Seng-Ryong Woo et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Transcriptional regulation of myeloid-derived suppressor cells
Thomas Condamine et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
The molecular basis for functional plasticity in type I interferon signaling
Gideon Schreiber et al.
TRENDS IN IMMUNOLOGY (2015)
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
Mahiru Kawano et al.
SCIENTIFIC REPORTS (2015)
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
Alessandra Romano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
Sabyasachi Bhattacharya et al.
EMBO MOLECULAR MEDICINE (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
Paul T. Thevenot et al.
IMMUNITY (2014)
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts
Sarah K. Maenhout et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis
Thomas Condamine et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Pathogenic potential of interferon αβ in acute influenza infection
Sophia Davidson et al.
NATURE COMMUNICATIONS (2014)
IL-6-stimulated CD11b+CD14+HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus
Miao-Fen Chen et al.
ONCOTARGET (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
Ang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
Serge Y. Fuchs
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
Nicole A. de Weerd et al.
NATURE IMMUNOLOGY (2013)
Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses
S. Bhattacharya et al.
ONCOGENE (2013)
Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia
Stefania Crotta et al.
PLOS PATHOGENS (2013)
Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2
Laura Icardi et al.
FASEB JOURNAL (2012)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Inflammatory signaling compromises cell responses to interferon alpha
W-C HuangFu et al.
ONCOGENE (2012)
Matrix Metalloproteinse-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12-and OX40L-Dependent Pathway
Emmanuelle Godefroy et al.
CANCER CELL (2011)
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Christine Zoglmeier et al.
CLINICAL CANCER RESEARCH (2011)
In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site
Jessica M. Haverkamp et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Role of p38 Protein Kinase in the Ligand-independent Ubiquitination and Down-regulation of the IFNAR1 Chain of Type I Interferon Receptor
Sabyasachi Bhattacharya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2
Hui Zheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Type I Interferon Signaling Regulates Ly6Chi Monocytes and Neutrophils during Acute Viral Pneumonia in Mice
Sang-Uk Seo et al.
PLOS PATHOGENS (2011)
Type I Interferons Regulate Cytolytic Activity of Memory CD8+ T Cells in the Lung Airways during Respiratory Virus Challenge
Jacob E. Kohlmeier et al.
IMMUNITY (2010)
Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon Receptor
Sabyasachi Bhattacharya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Type I interferon: friend or foe?
Giorgio Trinchieri
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Temporal and Spatial Resolution of Type I and III Interferon Responses In Vivo
Julia Elisabeth Pulverer et al.
JOURNAL OF VIROLOGY (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Induction of myeloid-derived suppressor cells by tumor exosomes
Xiaoyu Xiang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
Interferon-λ contributes to innate immunity of mice against influenza a virus but not against hepatotropic viruses
Markus Mordstein et al.
PLOS PATHOGENS (2008)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor
KGS Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
